TickerFiles

Biofrontera Inc. 10-Q filing

Filed 2025-11-12 · Report date 2025-09-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001493152-25-021945
Form type
10-Q
CIK
0001858685
Primary document
https://www.sec.gov/Archives/edgar/data/1858685/000149315225021945/form10-q.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for Biofrontera Inc..

Reported financial metrics

MetricCurrentPriorChange
Revenue$24.6M--
Operating Income$-15.9M--
Net Income$-16.2M--
Eps Basic-1.67--
Eps Diluted-1.67--
Cash And Equivalents$3.4M--
Total Assets$15.4M--
Total Liabilities$18.0M--
Shareholders Equity$-2.6M--
Operating Cash Flow$-11.0M--
Capital Expenditures$3,000--